Association of Treatment Intensity and Adherence to Lipid-Lowering Therapy with Major Adverse Cardiovascular Events Among Post-MI Patients in Germany

por Ahrens, Ingo, Khachatryan, Artak, Monga, Bondo, Dornstauder, Eugen, Sidelnikov, Eduard
Publicado 2021

Identification of Secondary Prevention Patients Eligible for PCSK9 Inhibitors Therapy According to the Routine Clinical Practice in Spain

por Cosin-Sales, Juan, Sidelnikov, Eduard, Villamayor, Santiago, Fernández, Miriam, Merino-Montero, Sandra, Zamora, Alberto
Publicado 2022

Healthcare Resource Utilization, Cardiovascular Event Rate and Use of Lipid-Lowering Therapies in Secondary Prevention of ASCVD in Hospitalized Patients in Italy

por Sciattella, Paolo, Maggioni, Aldo P., Arcangeli, Emanuela, Sidelnikov, Eduard, Kahangire, Doreen A., Mennini, Francesco S.
Publicado 2021

Longitudinal evaluation of treatment patterns, risk factors and outcomes in patients with cardiovascular disease treated with lipid-lowering therapy in the UK

por Danese, Mark, Sidelnikov, Eduard, Villa, Guillermo, Catterick, David, Iqbal, Mazhar, Gleeson, Michelle, Lubeck, Deborah, Patel, Jeetesh
Publicado 2022

Validity of a simple Internet-based outcome-prediction tool in patients with total hip replacement: a pilot study

por Stöckli, Cornel, Theiler, Robert, Sidelnikov, Eduard, Balsiger, Maria, Ferrari, Stephen M, Buchzig, Beatus, Uehlinger, Kurt, Riniker, Christoph, Bischoff-Ferrari, Heike A
Publicado 2014

European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction

por Qureshi, Nadeem, Antoniou, Sotiris, Cornel, Jan H., Schiele, Francois, Perrone-Filardi, Pasquale, Brachmann, Johannes, Sidelnikov, Eduard, Villa, Guillermo, Ferguson, Samara, Rowlands, Christina, González-Juanatey, José R.
Publicado 2022